Fujian Dongrui Pharmaceutical

Fujian Dongrui Pharmaceutical Co., Ltd. is a prominent subsidiary of Dawnrays Pharmaceutical (Holdings) Limited, specializing in the development, manufacture, and commercialization of high-quality generic pharmaceuticals. The company is a major player in the Chinese market, particularly known for its extensive portfolio of cephalosporin antibiotics and system-specific drugs for chronic conditions. Its core therapeutic focus includes cardiovascular diseases, metabolic disorders, and anti-viral treatments, with flagship products such as amlodipine besylate and entecavir. Operating from advanced manufacturing facilities in Fuzhou, the company adheres to strict GMP standards to ensure product safety and efficacy. Fujian Dongrui plays a critical role in the parent group's vertically integrated business model, supporting both domestic supply and international export initiatives.